CANO HEALTH INC (CANO)
US13781Y2028 - Common Stock
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 1.04M | N/A | |||
| Cash Equivalents | 41.30M | 27.30M | 163.20M | 33.80M | 29.20M | |||
| Receivables | 87.50M | 233.80M | 133.40M | 67.40M | 49.30M | |||
| Inventories | N/A | N/A | 1.10M | 900.00K | 600.00K | |||
| Other Current Assets | 15.90M | 79.60M | 19.50M | 8.90M | 3.80M | |||
| Total Current Assets | 144.70M | 340.70M | 317.20M | 111.00M | 82.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 243.80M | 309.20M | 217.40M | 38.10M | 19.20M | |||
| Investments And Advances | N/A | N/A | N/A | 690.31M | N/A | |||
| Goodwill | 88.90M | 480.40M | 769.70M | 234.30M | 142.10M | |||
| Intangibles | 729.20M | 793.80M | 825.60M | 226.40M | 75.60M | |||
| Other Non-Current Assets | 5.30M | 4.80M | 13.60M | 4.40M | 1.80M | |||
| Total Non-Current Assets | 1.07B | 1.59B | 1.83B | 503.20M | 243.20M | |||
| TOTAL ASSETS | 1.21B | 1.93B | 2.14B | 614.20M | 326.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 119.40M | 8.10M | 8.30M | 6.00M | 2.10M | |||
| Accrued Expenses | 23.00M | 24.10M | 15.30M | 2.18M | N/A | |||
| Accounts Payable | 135.90M | 105.70M | 72.80M | 31.40M | 12.70M | |||
| Other Current Liabilities | 87.70M | 70.50M | 64.70M | 29.80M | 71.30M | |||
| Total Current Liabilities | 365.90M | 208.40M | 161.00M | 67.20M | 86.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 959.00M | 1.00B | 918.80M | 459.20M | 134.00M | |||
| Other Non-Current Liabilities | 146.10M | 225.00M | 265.20M | 38.20M | 7.40M | |||
| Total Non-Current Liabilities | 968.10M | 1.47B | 1.66B | 497.40M | 141.80M | |||
| TOTAL LIABILITIES | 1.33B | 1.68B | 1.82B | 564.60M | 228.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -715.40M | -286.00M | -78.80M | -107.80M | -25.00M | |||
| Additional Paid In Capital | 593.30M | 538.60M | 397.40M | 0.00 | N/A | |||
| Minority Interest | 94.20M | 462.70M | 578.50M | 0.00 | 400.00K | |||
| Common Shares | 100.00K | 0.00 | 0.00 | 157.60M | 123.20M | |||
| Other Shareholders' Equity | N/A | N/A | 0.00 | -100.00K | -100.00K | |||
| Shares Outstanding | 5.40M | 271.00M | 299.20M | 308.50M | 308.50M | |||
| Tangible Book Value per Share | -174.11 | -3.77 | -4.27 | -1.33 | -0.39 | |||
| Total Shareholders' Equity | -122.10M | 252.60M | 318.70M | 49.60M | 98.10M | |||
| TOTAL LIABILITIES AND EQUITY | 1.21B | 1.93B | 2.14B | 614.20M | 326.10M | |||
| Statistics | ||||||||
| Debt/Equity | -7.85 | 3.96 | 2.88 | 9.26 | 1.37 | |||
| Current Ratio | 0.40 | 1.63 | 1.97 | 1.65 | 0.96 | |||
| Return On Assets (ROA) | -47.69% | -10.75% | -0.84% | -11.58% | -6.07% | |||
| Return On Equity (ROE) | N/A | -82.07% | -5.65% | -143.35% | -20.18% | |||
All data in USD